This new trial is a brilliant move! I don’t se
Post# of 148169
(Total Views: 550)
Posted On: 05/18/2020 10:39:07 AM
This new trial is a brilliant move!
I don’t see how the FDA could refuse.
They proclaimed Redemsivir to be the soc.
Surely they have sizeable knowledge about Leronlimabs safety profile and (“anecdotal”) effectiveness.
They’ve got to know that there is at least “a trend” it’s working.
If FDA denies this trial and later on Leronlimab proves to be the Covid lifesaver, they’re going to have a very hard time explaining to the public/media.
It’s very clear to me. The FDA can’t refuse.
I really liked inviting other countries to join such a trial. Putting even more pressure on the good old FDA.
Yes, there’ll be an awfull lot of explaining to do if the FDA blocks this trial.
I don’t see how the FDA could refuse.
They proclaimed Redemsivir to be the soc.
Surely they have sizeable knowledge about Leronlimabs safety profile and (“anecdotal”) effectiveness.
They’ve got to know that there is at least “a trend” it’s working.
If FDA denies this trial and later on Leronlimab proves to be the Covid lifesaver, they’re going to have a very hard time explaining to the public/media.
It’s very clear to me. The FDA can’t refuse.
I really liked inviting other countries to join such a trial. Putting even more pressure on the good old FDA.
Yes, there’ll be an awfull lot of explaining to do if the FDA blocks this trial.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼